Despite representing a small fraction of PCa cases (0.45%–1% and 1.2% for BRCA1 and BRCA2, respectively), studies have demonstrated that these patients present with a larger proportion of high‐grade and metastatic disease.5 Here, BRCA2 is linked to posterior cortical atrophy.